| The Global Epidemiology of Diabetes and Kidney Disease |
34 |
| Acute Kidney Injury and Progression of Diabetic Kidney Disease |
23 |
| Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience |
22 |
| Immune Dysfunction and Risk of Infection in Chronic Kidney Disease |
18 |
| Estimated Glomerular Filtration Rate; Laboratory Implementation and Current Global Status |
13 |
| Pragmatic Use of Kidney Function Estimates for Drug Dosing: The Tide Is Turning |
11 |
| Kidney Function in Obesity-Challenges in Indexing and Estimation |
10 |
| Inflammation, Immunity, and Oxidative Stress in Hypertension-Partners in Crime? |
10 |
| Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease |
10 |
| Magnesium and Cardiovascular Disease |
9 |
| Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease |
9 |
| Cardiorenal Syndrome: An Overview |
8 |
| Hypokalemic Distal Renal Tubular Acidosis |
7 |
| Incomplete Distal Renal Tubular Acidosis and Kidney Stones |
7 |
| Kinetic Glomerular Filtration Rate in Routine Clinical Practice-Applications and Possibilities |
7 |
| Measurement and Estimation of Residual Kidney Function in Patients on Dialysis |
7 |
| Bone-Vascular Axis in Chronic Kidney Disease |
7 |
| The Role of Vitamin K in Vascular Calcification |
7 |
| Estimated Glomerular Filtration Rate From a Panel of Filtration Markers-Hope for Increased Accuracy Beyond Measured Glomerular Filtration Rate? |
6 |
| Glomerular Filtration Rates in Asians |
6 |
| Current Concepts in Hemodialysis Vascular Access Infections |
6 |
| Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects |
6 |
| Challenges in Measuring Glomerular Filtration Rate: A Clinical Laboratory Perspective |
6 |
| Dietary Magnesium and Chronic Disease |
6 |
| Magnesium and Blood Pressure: A Physiology-Based Approach |
6 |
| Magnesium and Progression of Chronic Kidney Disease: Benefits Beyond Cardiovascular Protection? |
6 |
| Magnesium Balance and Measurement |
5 |
| Alternatives for the Bedside Schwartz Equation to Estimate Glomerular Filtration Rate in Children |
5 |
| Peritoneal Dialysis Access Associated Infections |
4 |
| The Impact of Anemia Treatment on Health-Related Quality of Life in Patients With Chronic Kidney Disease in the Contemporary Era |
4 |
| Resistant Hypertension: Diagnosis and Management |
4 |
| Assessment of Glomerular Filtration Rate and End-Stage Kidney Disease Risk in Living Kidney Donor Candidates: A Paradigm for Evaluation, Selection, and Counseling |
4 |
| Advanced Heart Failure Therapies and Cardiorenal Syndrome |
4 |
| Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial |
4 |
| Hepcidin |
3 |
| Magnesium as a Calcification Inhibitor |
3 |
| Treatment of Diabetic Kidney Disease With Hypertension Control and Renin Angiotensin System Inhibition |
3 |
| Kidney Diseases Associated With Parvovirus B Hanta, Ebola, and Dengue Virus Infection: A Brief Review |
3 |
| Diagnostic Tests for Vascular Calcification |
3 |
| Mineral Bone Abnormalities and Vascular Calcifications |
3 |
| Assessment of Kidney Function in Patients With Cancer |
3 |
| Measured GFR in Routine Clinical Practice-The Promise of Dried Blood Spots |
2 |
| Renal Tubular Acidosis: H+/Base and Ammonia Transport Abnormalities and Clinical Syndromes |
2 |
| Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients |
2 |
| The Impact of APOL1 on Chronic Kidney Disease and Hypertension |
2 |
| Valvular Calcification in Chronic Kidney Disease |
2 |
| Common Mechanisms of Viral Injury to the Kidney |
2 |
| The Changing Face of Human Immunodeficiency Virus-Mediated Kidney Disease |
2 |
| New Glucose-Lowering Agents for Diabetic Kidney Disease |
2 |
| Epidemiology of Cardiorenal Syndrome |
2 |
